Warning letter
Rx Vitamins, Inc: warning letter of Mar 17, 2016
FDA warning letter 482377 · New York District Office
Key facts
| Reference number | 482377 |
|---|---|
| Company | Rx Vitamins, Inc |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Mar 17, 2016 |
| Posted date | Mar 29, 2016 |
| Issuing office | New York District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.36, 111.55, 111.103, 111.105, 101.3(g), 101.4(h)(1), 101.9(b), 111.127(h), 101.36(b)(2)(i), 101.36(b)(3), 101.12(b), 201.5 |
| Inspection city | Elmsford |
| Inspection ZIP | 10523 |
| Inspection start date | Sep 21, 2015 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: